Author & year
|
Name of instrument
|
Construct
|
Number of
sub constructs/sub domains
|
Reliability
|
Validity
|
|
|
|
|
Internal consistency (subscales)
|
Test-retest
reliability
|
Construct validity
|
Content validity
|
Criterion validity
|
Morean et al., 2019
|
Sensory E-cigarette Expectancies Scale (SEES)
|
Sensory vaping expectancies
|
3 (taste/smell, pleasure/satisfaction, vapor cloud
Production)
|
Subscales: .85 - .90
|
NR
|
Test Dimensionality (EFA & CFA);
Measurement invariance;
Convergence with dependence
|
NR
|
Concurrent validity (associated with vaping frequency and habitual e-cigarette use)
|
|
|
|
|
Piper et al., 2019
|
E-cigarette Fagerström Test of Cigarette Dependence (e-FTCD)
|
E-cigarette dependence measure
|
1 (dependence)
|
.51
|
NR
|
Test Dimensionality (CFA); Correlation with e-cigarette use measures and; e-cigarette dependence measures
|
NR
|
Predictive validity (associated with e-cigarette use)
|
|
|
|
|
Piper et al., 2019
Piper et al., 2019
; Foulds et al., 2015
|
E-cigarette Wisconsin Inventory of Smoking Dependence Motives (e-WISDM)
|
E-cigarette dependence measure
|
11 (affiliative attachment, affective enhancement, automaticity, loss of control, cognitive enhancement, craving, cue exposure, social/environmental goals, taste, tolerance, weight control)
|
.80
|
NR
|
Test Dimensionality (CFA); Correlation with e-cigarette use measures and; e-cigarette dependence measures
|
NR
|
Predictive validity (associated with e-cigarette use)
|
|
|
|
|
Penn State Electronic Cigarette Dependence Index (PS-ECDI).
|
E-cigarette dependence measure
|
1 (dependence)
|
.74
|
NR
|
Test Dimensionality (CFA); Correlation with e-cigarette use measures and; e-cigarette dependence measures; Test differences by nicotine concentration of products used
|
Participant Interviews
|
Predictive validity (associated with e-cigarette use)
|
|
|
|
|
Dowd et al., 2019
|
Questionnaire of Vaping Craving (QVC)
|
Craving for e-cigarette measure
|
3 (desire, intention, positive outcome)
|
.96
|
NR
|
Test Dimensionality (PFA & CFA); Correlation with e-cigarette use, and cigarette use measures; Convergent and discriminant validity
|
NR
|
NR
|
|
|
|
|
Cole et al., 2019
|
Susceptibility scale
|
Susceptibility to future tobacco products or e-cigarettes use
|
1 (susceptibility)
|
NR
|
NR
|
NR
|
NR
|
Predictive validity (associated with e-cigarette use)
|
|
|
|
|
Pokhrel et al., 2018
|
Revised youth e-cigarette outcome expectancies
|
E-cigarette use outcome expectancies
|
8 (social enhancement, affect regulation, positive sensory experience, negative health consequences, addiction concern, negative sensory experience, positive “smoking” experience, negative social experience)
|
Subscales: .77 - .94
|
NR
|
Test Dimensionality (EFA & CFA); Convergence and divergence validity
|
NR
|
Concurrent validity (associated with e-cigarette use susceptibility, current e-cigarette use, e-cigarette use dependence)
|
|
|
|
|
Pokhrel et al., 2018
|
Revised youth EC outcome expectancies (short)
|
Outcome expectancies
|
2 (positive outcome expectancies, negative outcome expectancies)
|
.87 - .92
|
NR
|
Test Dimensionality (EFA & CFA)
|
NR
|
Concurrent validity (associated with e-cigarette use susceptibility, current e-cigarette use, e-cigarette use dependence); construct validity (associated with e-cigarette outcome expectancy factors)
|
|
|
|
|
Morean et al., 2018
|
Self-report habit index (SRHI)
|
Habitual e-cigarette use
|
1 (habitual use)
|
0.91
|
NR
|
Test Dimensionality (CFA & EFA); Measurement invariance;
|
NR
|
Concurrent validity (associated with increased frequency of e-cigarette use)
|
|
|
|
|
Carey et al., 2018
|
Susceptibility to four product classes (EC, cigars, hookah and cigarettes)
|
Susceptibility to four product classes (e-cigarette, cigarettes, hookah and cigars)
|
4 (e-cigarettes, cigarettes, hookah, cigars)
|
0.74
|
NR
|
Test Dimensionality (CFA)
|
NR
|
Concurrent validity (associated with e-cigarette ever use)
|
|
|
|
|
Browne & Todd, 2018
|
Fagerström Test for Nicotine Dependence applied to Vaping
(FTND-V)–
|
E-cigarette dependence and consumption
|
1
|
.54
|
NR
|
Test Dimensionality (CFA)
|
NR
|
NR
|
|
|
|
|
Hershberger et al., 2017
|
Comparing E-Cigarette and Cigarettes Questionnaire(CEAC)
|
Comparative beliefs of e-cig use and cigarette
smoking
|
3 (general benefits, general effects; health benefits
|
0.94
Subscales: .80-.88
|
NR
|
Test Dimensionality (EFA & CFA); Measurement invariance
|
NR
|
NR
|
|
|
|
|
Waters et al., 2017
|
Perceived harms and social norms in the use of
electronic cigarettes
|
Perceived harms and social norms
|
1 (perceived harms), 1 (social norm)
|
.87 (perceived harms) .93 (social norm)
|
NR
|
Test Dimensionality (EFA)
|
NR
|
Concurrent validity (associated with e-cigarette use)
|
|
|
|
|
Persoskie et al., 2017
|
Direct and indirect measures of perceived harm of e-cigarettes and smokeless tobacco
|
Perceived harm of e-cigarettes
|
2 (direct and indirect)
|
NR
|
NR
|
NR
|
NR
|
Concurrent validity (associated with e-cigarette use)
|
|
|
|
|
Copeland et al., 2017
|
Risk and Benefits of E-cigarettes (RABE)
|
Perceived risk and benefits of e-cigarette use (RABE)
|
2 (perceived risks, perceived benefits)
|
Subscales: .89 - .92
|
NR
|
Test Dimensionality (CFA);
Test differences by e-cigarette use status);
Correlation with Cigarette Dependent Index
|
NR
|
NR
|
|
|
|
|
Morean & L’Insalata, 2017
|
Short Form Vaping Consequences Questionnaire (S-VCQ)
|
Sensory vaping
expectancies
|
4 (Negative consequences, Positive reinforcement, Negative reinforcement, Appetite/weight control)
|
Subscale: .85 - .94
|
NR
|
Test Dimensionality (CFA); Measurement invariance;
Correlation with smoking expectancy scale
|
NR
|
Concurrent validity (associated with frequency of e-cigarette use)
|
|
|
|
|
Penzes et al., 2016
|
Motivations of intention to try EC
|
Motivations of intention to try e-cigarette
|
6 (health benefits/smoking cessation; curiosity/taste variety; perceived social norms; convenience; chemical hazards; danger of dependence)
|
subscale: .68-.90
|
NR
|
Test Dimensionality (EFA)
|
NR
|
Concurrent validity (subscales (curiosity/taste) associated with e-cigarette experimentation)
|
|
|
|
|
Hershberger et al., 2016
|
Nicotine and Other Substance Interaction Expectancy Questionnaire E-cig Revised version (NOSIE-ER)
|
Expectancies of combined e-cig and alcohol use
|
2 (alcohol use leads to e-cigarette use,
e-cigarette use leads to alcohol use)
|
.84 -.88 Subscale: .85-.94
|
NR
|
Test Dimensionality (EFA & CFA)
|
NR
|
Concurrent validity (associated with alcohol use disorder)
|
|
|
|
|
Hendricks et al., 2015
|
E-cigarette-specific Brief Smoking Consequences Questionnaire-Adult (BSCQ-A)
|
Hospitalized smokers' expectancies for electronic cigarettes
|
10 (negative affect reduction, stimulation/state enhancement, health risks, taste/sensorimotor manipulation, social facilitation, weight control, craving/addiction, negative physical feelings, boredom reduction, negative social impression)
|
.67 - .88
|
NR
|
Test Dimensionality (CFA);
Correlations with tobacco use, and e-cigarette exposure and use
|
NR
|
Concurrent validity (associated with intention to use e-cigarettes)
|
|
|
|
|
Chaffee et al., 2015
|
Conditional Risk Assessment of Adolescents’ Electronic Cigarette Perceptions
|
Perceived risk and benefits for use of e-cigarette
|
2 (perceived risks and benefits)
|
NR
|
NR
|
Test differences by e-cigarette use status; Correlation with Cigarette Dependent Index
|
NR
|
Concurrent validity (associated with e-cigarette use)
|
|
|
|
|